• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Innospec Reports Second Quarter 2025 Financial Results

    8/5/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials
    Get the next $IOSP alert in real time by email

    Strong growth in Fuel Specialties operating income offsetting lower results in our other businesses

    Focus on sequential gross margin and operating income improvement in the second half of the year

    Debt-free balance sheet with over $266 million in net cash; $8.2 million in share repurchases

    GAAP EPS 94 cents and adjusted non-GAAP EPS $1.26

    ENGLEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the second quarter ended June 30, 2025.

    Total revenues for the second quarter were $439.7 million, an increase of 1 percent from $435.0 million in the corresponding period last year. Net income for the quarter was $23.5 million or 94 cents per diluted share compared to $31.2 million or $1.24 per diluted share recorded last year. Adjusted EBITDA for the quarter was $49.1 million compared to $54.1 million reported in the same period a year ago.

    Results for this quarter include some special items, which are summarized in the table below. Excluding these items, adjusted non-GAAP EPS in the second quarter was $1.26 per diluted share, compared to $1.39 per diluted share a year ago.

    Cash from operating activities was $9.3 million before capital expenditures of $16.2 million. The quarter closed with net cash of $266.6 million. In the second quarter, the Company paid its semi-annual dividend of 84 cents per common share and repurchased 89,778 of its common shares under the share repurchase program at a cost of $20.8 million and $8.2 million respectively.

    Adjusted EBITDA, income before income taxes excluding special items and net income excluding special items and related per-share amounts together with net cash, are non-GAAP financial measures that are defined and reconciled with GAAP results herein and in the schedules below.

      Quarter ended June 30, 2025

     Quarter ended June 30, 2024
    (in millions, except share and per share data) Income before

    income taxes
      Net

    income
      Diluted EPS  Income before

    income taxes
      Net income  Diluted EPS
                      
    Reported GAAP amounts$31.9 $23.5 $0.94 $43.7 $31.2 $1.24
                      
    Foreign currency exchange losses 4.7  3.5  0.14  0.1  0.1  -
    Legacy costs of closed operations 3.0  2.3  0.09  0.8  0.6  0.02
    Amortization of acquired intangible assets 2.1  1.6  0.06  3.2  2.4  0.10
    Adjustment to fair value of contingent consideration 0.8  0.8  0.03  0.6  0.4  0.02
    Adjustment of income tax provisions -  -  -  -  0.2  0.01
      10.6  8.2  0.32  4.7  3.7  0.15
                      
    Adjusted non-GAAP amounts$42.5 $31.7 $1.26 $48.4 $34.9 $1.39
     

    Commenting on the second quarter results, Patrick S. Williams, President and Chief Executive Officer, said,

    "This was a balanced quarter overall for Innospec. Our diversified portfolio again benefited from strong growth in Fuel Specialties operating income, offsetting lower results in Performance Chemicals and Oilfield Services.

    Performance Chemicals delivered strong sales growth with a nine percent increase on the prior year driven by lower margin products. As a consequence gross margins fell short of our expectations. Gross margin improvement is a key priority in Performance Chemicals, and our team remains focused on delivering sequential growth in the coming quarters. We continue to see general customer caution in the short term. In the medium term, we intend to accelerate margin-accretive opportunities across all our end markets. We expect no change in our customers' drive towards clean, mild and performance-boosting technologies, in which Innospec is exceptionally well placed.

    Fuel Specialties had another strong quarter with a double-digit increase in operating income over the prior year. As expected, the business has continued to deliver consistent results through the current economic uncertainty. We remain focused on achieving full year operating income growth and margin improvement in this business.

    As anticipated, Oilfield Services operating income improved on a sequential basis but declined against the prior year. We remain focused on driving further sequential operating income growth through a combination of top-line initiatives, cost management and other near-term improvement opportunities in the second half of this year. Our outlook does not expect any resumption of Latin America activity for the remainder of the year."

    Revenues in Performance Chemicals of $173.8 million were up 9 percent over the second quarter of last year. Volumes grew 4 percent with a positive price/mix of 2 percent and a positive currency impact of 3 percent. Gross margins of 17.5 percent decreased by 5.1 percentage points from the same quarter last year. Operating income of $14.3 million decreased 33 percent from $21.2 million in the corresponding prior year period.

    Revenues in Fuel Specialties of $165.1 million were down 1 percent from $166.6 million in the second quarter of last year. Volumes were down 7 percent with price/mix up 4 percent and a positive currency impact of 2 percent. Gross margins of 38.1 percent increased by 3.5 percentage points over last year. Operating income of $35.4 million increased 16 percent from $30.4 million a year ago.

    Revenues in Oilfield Services of $100.8 million for the quarter were down 7 percent from $108.3 million in the second quarter of last year. Gross margins of 29.6 percent decreased by 1.0 percentage point from the same quarter last year on a weaker sales mix. Operating income of $6.2 million decreased 15 percent from $7.3 million in the prior year period.

    Corporate costs for the quarter of $20.9 million included a $2.3 million legacy environmental provision, compared with $17.6 million a year ago.

    The effective tax rate for the quarter was 26.3 percent compared to 28.6 percent in the same period last year reflecting the geographical location of taxable profits.

    For the quarter, cash provided by operating activities was $9.3 million compared to $4.7 million a year ago. As of June 30, 2025, Innospec had $266.6 million in cash and cash equivalents and no debt.

    Mr. Williams concluded,

    "We continue to prioritize gross margin and operating income improvement in the near term in Performance Chemicals and Oilfield Services, which we intend to deliver in the second half of 2025. We remain focused on a combination of sales, cost actions, new technology commercialization and other improvement opportunities across all regions and end-markets. In addition, we expect Fuel Specialties to continue to deliver good results.

    Operating cash generation was positive in the quarter, and our net cash position closed at over $266 million. We have significant balance sheet flexibility for M&A, dividend growth, organic investment and buybacks. This quarter we continued our record of returning value to shareholders with our semi-annual dividend of 84 cents per share and $8.2 million in share repurchases." 

    Use of Non-GAAP Financial Measures

    The information presented in this press release includes financial measures that are not calculated or presented in accordance with Generally Accepted Accounting Principles in the United States (GAAP). These non-GAAP financial measures comprise adjusted EBITDA, income before income taxes excluding special items, net income excluding special items and related per share amounts together with net cash. Adjusted EBITDA is net income per our consolidated financial statements adjusted for the exclusion of interest income, net, income taxes, depreciation and amortization, foreign currency exchange losses/(gains), legacy costs of closed operations and adjustment to fair value of contingent consideration. Income before income taxes, net income and diluted EPS, excluding special items, per our consolidated financial statements are adjusted for the exclusion of foreign currency exchange losses, legacy costs of closed operations, amortization of acquired intangible assets, adjustment to fair value of contingent consideration and adjustment of income tax provisions. Net cash is cash and cash equivalents less total debt. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided herein and in the schedules below. The Company believes that such non-GAAP financial measures provide useful information to investors and may assist them in evaluating the Company's underlying performance and identifying operating trends. In addition, these non-GAAP measures address questions the Company routinely receives from analysts and investors and the Company has determined that it is appropriate to make this data available to all investors. While the Company believes that such measures are useful in evaluating the Company's performance, investors should not consider them to be a substitute for financial measures prepared in accordance with GAAP. In addition, these non-GAAP financial measures may differ from similarly titled non-GAAP financial measures used by other companies and do not provide a comparable view of the Company's performance relative to other companies in similar industries. Management uses adjusted EPS (the most directly comparable GAAP financial measure for which is GAAP EPS) and net income excluding special items and adjusted EBITDA (the most directly comparable GAAP financial measure for which is GAAP net income) to allocate resources and evaluate the performance of the Company's operations and has provided a reconciliation of adjusted EBITDA and net income excluding special items, and related per share amounts, to GAAP net income herein and in the schedules below.

    About Innospec Inc.

    Innospec Inc. is an international specialty chemicals company with approximately 2,450 employees in 22 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. The Performance Chemicals business creates innovative technology-based solutions for our customers in the Personal Care, Home Care, Agrochemical, Mining and Industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Oilfield Services provides specialty chemicals to all elements of the oil and gas exploration and production industry. 

    Forward-Looking Statements

    This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like "expects," "estimates," "anticipates," "may," "could," "believes," "feels," "plans," "intends," "outlook" or similar words or expressions, for example) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future. Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements. Additional information regarding risks, uncertainties and assumptions relating to Innospec and affecting our business operations and prospects are described in Innospec's Annual Report on Form 10-K for the year ended December 31, 2024, Innospec's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 and other reports filed with the U.S. Securities and Exchange Commission. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading "Risk Factors" in such reports. Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    Contacts:

    Corbin Barnes

    Innospec Inc.

    +44-151-355-3611

    [email protected]



    INNOSPEC INC. AND SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF INCOME
     
    Schedule 1
     
    (in millions, except share and per share data)

     Three Months Ended

    June 30
     Six Months Ended

    June 30
    2025  2024  2025  2024 
                 
    Net sales$439.7 $435.0 $880.5 $935.2 
    Cost of goods sold (316.5) (308.1) (632.2) (652.6)
    Gross profit 123.2  126.9  248.3  282.6 
                 
    Operating expenses:            
    Selling, general and administrative (74.6) (71.6) (143.9) (162.1)
    Research and development (13.6) (14.0) (26.3) (28.0)
    Adjustment to fair value of contingent consideration (0.8) (0.6) (1.5)) (1.4)
    Profit on disposal of property, plant and equipment 0.1  -  0.2  0.1 
    Total operating expenses (88.9) (86.2) (171.5) (191.4)
    Operating income 34.3  40.7  76.8  91.2 
    Other (expense)/income, net (5.1) 0.9  (5.6) 3.6 
    Interest income, net 2.7  2.1  5.1  4.2 
    Income before income taxes 31.9  43.7  76.3  99.0 
    Income taxes (8.4) (12.5) (20.0) (26.4)
    Net income$23.5 $31.2 $56.3 $72.6 
                 
    Earnings per share:            
    Basic$0.94 $1.25 $2.26 $2.91 
    Diluted$0.94 $1.24 $2.24 $2.89 
                 
    Weighted average shares outstanding (in thousands):            
    Basic 24,937  24,937  24,954  24,918 
    Diluted 25,042  25,097  25,097  25,091 
                



    INNOSPEC INC. AND SUBSIDIARIES
     
    Schedule 2A
     
    SEGMENTAL ANALYSIS OF RESULTS Three Months Ended

    June 30
     Six Months Ended

    June 30
    (in millions) 2025

     2024

     2025

     2024

                 
    Net sales:            
    Performance Chemicals$173.8 $160.1 $342.2 $320.9 
    Fuel Specialties 165.1  166.6  335.4  343.5 
    Oilfield Services 100.8  108.3  202.9  270.8 
      439.7  435.0  880.5  935.2 
                 
    Gross profit:            
    Performance Chemicals 30.5  36.2  65.8  73.9 
    Fuel Specialties 62.9  57.6  123.7  118.2 
    Oilfield Services 29.8  33.1  58.8  90.5 
      123.2  126.9  248.3  282.6 
                 
    Operating income:            
    Performance Chemicals 14.3  21.2  34.1  42.3 
    Fuel Specialties 35.4  30.4  72.3  63.8 
    Oilfield Services 6.2  7.3  10.3  24.2 
    Corporate costs (20.9) (17.6) (38.6) (37.8)
      35.0  41.3  78.1  92.5 
    Adjustment to fair value of contingent consideration (0.8) (0.6) (1.5) (1.4)
    Profit on disposal of property, plant and equipment 0.1  -  0.2  0.1 
    Total operating income$34.3 $40.7 $76.8 $91.2 

     

    Schedule 2B
     
    NON-GAAP MEASURES Three Months Ended

    June 30
     Six Months Ended

    June 30
    (in millions) 2025

     2024

     2025

     2024

                 
    Net income$23.5 $31.2 $56.3 $72.6 
    Interest income, net (2.7) (2.1) (5.1) (4.2)
    Income taxes 8.4  12.5  20.0  26.4 
    Depreciation and amortization 11.4  11.0  22.3  21.3 
    Foreign currency exchange losses/(gains) 4.7  0.1  4.3  (1.0)
    Legacy costs of closed operations 3.0  0.8  3.8  1.6 
    Adjustment to fair value of contingent consideration 0.8  0.6  1.5  1.4 
    Adjusted EBITDA 49.1  54.1  103.1  118.1 
                 



    Schedule 3
    INNOSPEC INC. AND SUBSIDIARIES

    CONDENSED CONSOLIDATED BALANCE SHEETS
     


    (in millions)
     June 30,

    2025

     December 31,

    2024

       
    Assets  
           
    Current assets:      
    Cash and cash equivalents$266.6 $289.2 
    Trade and other accounts receivable 336.1  341.7 
    Inventories 336.8  301.0 
    Prepaid expenses 13.7  21.0 
    Prepaid income taxes 12.1  3.1 
    Other current assets 4.4  0.6 
    Total current assets 969.7  956.6 
           
    Net property, plant and equipment 295.8  269.7 
    Operating lease right-of-use assets 49.3  44.8 
    Goodwill 397.6  382.5 
    Other intangible assets 78.3  65.4 
    Deferred tax assets 8.9  9.4 
    Pension asset -  2.4 
    Other non-current assets 6.5  3.9 
    Total assets$1,806.1 $1,734.7 
           
    Liabilities and Stockholders' Equity      
           
    Current liabilities:      
    Accounts payable$149.4 $163.8 
    Accrued liabilities 163.5  169.1 
    Current portion of operating lease liabilities 15.6  13.9 
    Current portion of plant closure provisions 5.0  5.0 
    Accrued income taxes 3.9  19.6 
    Total current liabilities 337.4  371.4 
           
    Operating lease liabilities, net of current portion 33.7  31.0 
    Plant closure provisions, net of current portion 63.8  55.3 
    Deferred tax liabilities 24.0  23.5 
    Pension liabilities and post-employment benefits 13.9  13.1 
    Acquisition-related contingent consideration 24.5  20.1 
    Other non-current liabilities 7.3  4.2 
    Equity 1,301.5  1,216.1 
    Total liabilities and equity$1,806.1 $1,734.7 
     



    Schedule 4
    INNOSPEC INC. AND SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
     
      Six Months Ended
    June 30

    (in millions) 2025

     2024

           
    Cash Flows from Operating Activities      
           
    Net income$56.3 $72.6 
    Adjustments to reconcile net income to cash provided by operating activities:      
    Depreciation and amortization 22.0  21.5 
    Adjustment to fair value of contingent consideration 1.5  1.4 
    Deferred taxes (0.6) 0.7 
    Profit on disposal of property, plant and equipment (0.2) (0.1)
    Non-cash movements on defined benefit pension plans 2.6  (1.6)
    Stock option compensation 4.1  4.2 
    Changes in working capital (22.6) (10.0)
    Movements in plant closure provisions 1.4  (0.1)
    Movements in income taxes (22.9) (0.1)
    Movements in unrecognized tax benefits -  (2.9)
    Movements in other assets and liabilities (4.0) (0.3)
    Net cash provided by operating activities 37.6  85.3 
           
    Cash Flows from Investing Activities      
           
    Capital expenditures (21.4) (21.6)
    Proceeds on disposal of property, plant and equipment 0.5  0.2 
    Business combinations, net of cash acquired -  (0.2)
    Internally developed software (10.8) (8.1) 
    Net cash used in investing activities (31.7) (29.7)
           
    Cash Flows from Financing Activities      
           
    Non-controlling interest 1.2  0.8 
    Refinancing costs -  (0.3)
    Dividend paid (20.8) (19.0)
    Issue of treasury stock 0.4  0.8 
    Repurchase of common stock (13.3) (0.7)
    Net cash used in financing activities (32.5) (18.4)
           
    Effect of foreign currency exchange rate changes on cash 4.0  (0.7)
    Net change in cash and cash equivalents (22.6) 36.5 
    Cash and cash equivalents at beginning of period 289.2  203.7 
    Cash and cash equivalents at end of period$266.6 $240.2 
           


    Primary Logo

    Get the next $IOSP alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IOSP

    DatePrice TargetRatingAnalyst
    4/21/2025$115.00Neutral → Buy
    Seaport Research Partners
    3/30/2022Neutral
    Seaport Research Partners
    More analyst ratings

    $IOSP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Innospec Reports Second Quarter 2025 Financial Results

    Strong growth in Fuel Specialties operating income offsetting lower results in our other businesses Focus on sequential gross margin and operating income improvement in the second half of the year Debt-free balance sheet with over $266 million in net cash; $8.2 million in share repurchases GAAP EPS 94 cents and adjusted non-GAAP EPS $1.26 ENGLEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the second quarter ended June 30, 2025. Total revenues for the second quarter were $439.7 million, an increase of 1 percent from $435.0 million in the corresponding period last year. Net income for the quarter was $23.5 million o

    8/5/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Innospec Schedules Second Quarter 2025 Earnings Release and Conference Call

    ENGLEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it will release second quarter 2025 earnings results on Tuesday, August 5, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, August 6, 2025, at 10:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal

    7/2/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Innospec Reports First Quarter 2025 Financial Results

    Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend increased by 10 percent; $50 million buyback initiated; Flexible debt-free balance sheet GAAP EPS of $1.31 and adjusted non-GAAP EPS of $1.42 ENGLEWOOD, Colo., May 08, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the first quarter ended March 31, 2025. The Company declared its semi-annual dividend of 84 cents per common share for the first half of this year, representing an increase of 10 per

    5/8/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Innospec upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded Innospec from Neutral to Buy and set a new price target of $115.00

    4/21/25 8:30:53 AM ET
    $IOSP
    Major Chemicals
    Industrials

    Seaport Research Partners initiated coverage on Innospec

    Seaport Research Partners initiated coverage of Innospec with a rating of Neutral

    3/30/22 7:37:48 AM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Parrette Leslie J sold $40,421 worth of shares (446 units at $90.63), decreasing direct ownership by 8% to 5,497 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    5/15/25 9:11:51 PM ET
    $IOSP
    Major Chemicals
    Industrials

    SVP, HUMAN RESOURCES Griffin Hardy Louis Iii covered exercise/tax liability with 600 shares, decreasing direct ownership by 8% to 6,742 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    5/15/25 9:05:37 PM ET
    $IOSP
    Major Chemicals
    Industrials

    SVP, Corporate Dev and IR Barnes Corbin covered exercise/tax liability with 740 shares, decreasing direct ownership by 8% to 8,998 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    5/15/25 9:01:11 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    SEC Filings

    View All

    SEC Form 10-Q filed by Innospec Inc.

    10-Q - INNOSPEC INC. (0001054905) (Filer)

    8/6/25 10:25:38 AM ET
    $IOSP
    Major Chemicals
    Industrials

    SEC Form 8-K filed by Innospec Inc.

    8-K - INNOSPEC INC. (0001054905) (Filer)

    8/6/25 6:07:39 AM ET
    $IOSP
    Major Chemicals
    Industrials

    SEC Form SD filed by Innospec Inc.

    SD - INNOSPEC INC. (0001054905) (Filer)

    5/30/25 6:04:36 AM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Parrette Leslie J bought $15,135 worth of shares (143 units at $105.84), increasing direct ownership by 3% to 4,734 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    8/14/24 6:31:38 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Parrette Leslie J bought $24,867 worth of shares (189 units at $131.57), increasing direct ownership by 4% to 4,591 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    5/20/24 6:07:17 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Parrette Leslie J bought $50,824 worth of shares (410 units at $123.96), increasing direct ownership by 13% to 3,620 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    2/23/24 6:19:14 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Financials

    Live finance-specific insights

    View All

    Innospec Reports Second Quarter 2025 Financial Results

    Strong growth in Fuel Specialties operating income offsetting lower results in our other businesses Focus on sequential gross margin and operating income improvement in the second half of the year Debt-free balance sheet with over $266 million in net cash; $8.2 million in share repurchases GAAP EPS 94 cents and adjusted non-GAAP EPS $1.26 ENGLEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the second quarter ended June 30, 2025. Total revenues for the second quarter were $439.7 million, an increase of 1 percent from $435.0 million in the corresponding period last year. Net income for the quarter was $23.5 million o

    8/5/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Innospec Schedules Second Quarter 2025 Earnings Release and Conference Call

    ENGLEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it will release second quarter 2025 earnings results on Tuesday, August 5, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, August 6, 2025, at 10:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal

    7/2/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Innospec Reports First Quarter 2025 Financial Results

    Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend increased by 10 percent; $50 million buyback initiated; Flexible debt-free balance sheet GAAP EPS of $1.31 and adjusted non-GAAP EPS of $1.42 ENGLEWOOD, Colo., May 08, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the first quarter ended March 31, 2025. The Company declared its semi-annual dividend of 84 cents per common share for the first half of this year, representing an increase of 10 per

    5/8/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Leadership Updates

    Live Leadership Updates

    View All

    Innospec Appoints Leslie J. Parrette as Non-Employee Director

    ENGLEWOOD, Colo., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it has appointed Mr. Leslie J. Parrette as a non-employee director, effective January 1, 2022. Mr. Parrette has 14 years experience in private practice as a corporate and transaction lawyer. He subsequently spent 20 years as General Counsel for public companies in domestic and international markets. Most recently, he served as Senior Vice President, General Counsel, Compliance Officer and Corporate Secretary of Novelis Inc., a leading producer of flat-rolled aluminum products and the world's largest recycler of aluminum. He is Founder and President of One Page Thinking, a data visualizatio

    12/6/21 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

    SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

    2/13/24 5:06:27 PM ET
    $IOSP
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

    SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

    2/9/24 2:18:58 PM ET
    $IOSP
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

    SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

    1/12/24 8:24:55 AM ET
    $IOSP
    Major Chemicals
    Industrials